Welltower (FRA:HCW) Research & Development: €0 Mil (TTM As of Mar. 2026)


FRA:HCW Welltower Inc FRA:HCW
85 GF Score
Price €195.70
GF Value €157.80
Valuation Modestly Overvalued
! 11 Warning Signs
View Full Analysis

What is Welltower Research & Development?

Welltower FRA:HCW +2.76% 85 Research & Development is €0 Mil as of Mar. 2026. GuruFocus rates FRA:HCW with a GF Score™ of 85/100 and a GF Value™ of €157.80 (Modestly Overvalued). The stock has 11 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Welltower's Research & Development for the three months ended in Mar. 2026 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0 Mil.

Welltower  (FRA:HCW) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Welltower Research & Development Related Terms

Welltower Research & Development Historical Data

* Premium members only.

The historical data trend for Welltower's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Welltower Research & Development Chart

Welltower Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Welltower Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:HCW
85GF Score
Welltower Inc FRA:HCW
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Welltower Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0 Mil mean?
Welltower (FRA:HCW) has a Research & Development of €0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Welltower and its competitors.
Is Welltower's Research & Development too high?
Welltower's current Research & Development is €0 Mil. Overall, Welltower has a GF Score™ of 85/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Welltower's Research & Development compare to VTR and OHI?
Welltower's Research & Development of €0 Mil can be compared against companies in the REITs industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a REITs company?
A good Research & Development depends on the REITs industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Welltower and its competitors. Welltower's current Research & Development is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Welltower stock overvalued right now?
Based on GuruFocus' analysis, Welltower (FRA:HCW) is currently considered Modestly Overvalued. The stock's GF Value™ is €157.80, compared to a current price of €195.70 — trading 24% above its estimated fair value. The current Research & Development is €0 Mil. Welltower's overall GF Score™ is 85/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Welltower (FRA:HCW), the current Research & Development is €0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Welltower (FRA:HCW) Overvalued in 2026?

Based on GuruFocus' analysis, Welltower stock appears to be overvalued. The current stock price of €195.70 is trading 24% above its estimated GF Value™ of €157.80. GuruFocus considers Welltower to be Modestly Overvalued.

Key valuation signals for FRA:HCW:

  • Research & Development: €0 Mil
  • GF Value™: €157.80 vs. price of €195.70 (24% above fair value)
  • GF Score™: 85/100 with 11 warning signs

No single metric tells the full story. See the FRA:HCW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Welltower Business Description

Industry Real EstateREITs
Address 4500 Dorr Street, Toledo, OH, USA, 43615
Welltower owns a diversified healthcare portfolio of 2,800 in-place properties spread across the senior housing, medical office, and skilled nursing/postacute care sectors. The portfolio includes over 900 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to that of the United States.
85GF Score

Get the complete analysis for FRA:HCW

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€195.70
Price
€157.80
GF Value